1. [O4–06–01]: SP1‐MODULATING COMPOUNDS AS A NOVEL DRUG TARGET FOR ALZHEIMER'S DISEASE (AD). (1st July 2017) Authors: Bayon, Baindu L.; Maloney, Bryan; Chopra, Nipun; White, Fletcher A.; Xu, Xiao‐Ming; Ratan, Rajiv R.; Lahiri, Debomoy K. Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 26 Page Start: P1241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P2–159]: DOES THE "BIOCHEMICAL INVERSION" OF ALZHEIMER's DISEASE AND AUTISM SPECTRUM DISORDER PROVIDE LATE‐LIFE PROTECTION FROM AN EARLY‐LIFE CONDITION?. (1st July 2017) Authors: Lahiri, Debomoy K.; Maloney, Bryan; Ray, Balmiki; Sokol, Deborah K. Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 13 Page Start: P668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A cardinal sin when researching neuropsin/KLK8: Thou shalt validate antibodies. Issue 9 (18th July 2017) Authors: Lahiri, Debomoy K.; Konar, Arpita; Thakur, Mahendra K.; Maloney, Bryan Journal: Alzheimer's & dementia Issue: Volume 13:Issue 9(2017) Page Start: 1068 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alteration of a specific microRNA regulating neprilysin expression in Alzheimer's disease. (1st February 2022) Authors: Lahiri, Debomoy K; Wang, Ruizhi; Maloney, Bryan; Chopra, Nipun; Beck, John S; Counts, Scott E. Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Alteration of a specific microRNA regulating neprilysin expression in Alzheimer's disease. (December 2021) Authors: Lahiri, Debomoy K; Wang, Ruizhi; Maloney, Bryan; Chopra, Nipun; Beck, John S; Counts, Scott E. Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Awsworth Through Time. (2012) Authors: Maloney, Bryan Record Type: Book Extent: 1 online resource (96 pages) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Epigenetics of dementia: understanding the disease as a transformation rather than a state. Issue 7 (June 2016) Authors: Maloney, Bryan; Lahiri, Debomoy K Journal: Lancet neurology Issue: Volume 15:Issue 7(2016:Jun.) Page Start: 760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Gene × environment interaction by a longitudinal epigenome-wide association study (LEWAS) overcomes limitations of genome-wide association study (GWAS). (December 2012) Authors: Lahiri, Debomoy K; Maloney, Bryan Journal: Epigenomics Issue: Volume 4:Number 6(2012) Page Start: 685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Human microRNA‐298 plays a vital role in maintaining APP and tau homeostasis and IL‐induced inflammation: Implication in Alzheimer's disease. (20th December 2022) Authors: Wang, Ruizhi; Maloney, Bryan; Long, Justin M; Sambamurti, Kumar; Counts, Scott E.; Lahiri, Debomoy K Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Lessons from a BACE1 inhibitor trial: Off‐site but not off base. (14th February 2014) Authors: Lahiri, Debomoy K.; Maloney, Bryan; Long, Justin M.; Greig, Nigel H. Journal: Alzheimer's & dementia Issue: Volume 10(2014)Supplement 5 Page Start: S411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗